IDEAS home Printed from https://ideas.repec.org/a/spr/aphecp/v20y2022i3d10.1007_s40258-021-00711-y.html
   My bibliography  Save this article

Herd Immunity Effects in Cost-Effectiveness Analyses among Low- and Middle-Income Countries

Author

Listed:
  • Siyu Ma

    (The Institute for Clinical Research and Health Policy Studies, Tufts Medical Center)

  • Tara A. Lavelle

    (The Institute for Clinical Research and Health Policy Studies, Tufts Medical Center
    Tufts University School of Medicine)

  • Daniel A. Ollendorf

    (The Institute for Clinical Research and Health Policy Studies, Tufts Medical Center
    Tufts University School of Medicine)

  • Pei-Jung Lin

    (The Institute for Clinical Research and Health Policy Studies, Tufts Medical Center
    Tufts University School of Medicine)

Abstract

Background Herd immunity (HI) is a key benefit of vaccination programs, but the effects are not routinely included in cost-effectiveness analyses (CEAs). Objective This study investigated how the inclusion of HI in CEAs may influence the reported value of immunizations in low- and middle-income countries (LMICs) and illustrated the implications for COVID-19 immunization. Methods We reviewed immunization CEAs published from 2000 to 2018 focusing on LMICs using data from the Tufts Medical Center CEA Registries. We investigated the proportion of studies that included HI, the methods used, and the incremental cost-effectiveness ratios (ICERs) reported. When possible, we evaluated how ICERs would change with and without HI. Results Among the 243 immunization CEAs meeting inclusion criteria, 44 studies (18%) included HI. Of those studies, 11 (25%) used dynamic transmission models, whereas the remainder used static models. Sixteen studies allowed for ICER calculations with and without HI (n = 48 ratios). The inclusion of HI always resulted in more favorable ratios. In 20 cases (42%), adding HI decreased the ICERs enough to cross at least one or more common cost-effectiveness benchmarks for LMICs. Among pneumococcal vaccination studies, including HI in the analyses decreased seven of 24 ICERs enough to cross at least one cost-effectiveness benchmark. Conclusion The full value of immunization may be underestimated without considering a scenario in which HI is achieved. Given the evidence in pneumococcal CEAs, COVID-19 vaccine value assessments should aim to show ICERs with and without HI to inform decision-making in LMICs.

Suggested Citation

  • Siyu Ma & Tara A. Lavelle & Daniel A. Ollendorf & Pei-Jung Lin, 2022. "Herd Immunity Effects in Cost-Effectiveness Analyses among Low- and Middle-Income Countries," Applied Health Economics and Health Policy, Springer, vol. 20(3), pages 395-404, May.
    • Handle: RePEc:spr:aphecp:v:20:y:2022:i:3:d:10.1007_s40258-021-00711-y
    DOI: 10.1007/s40258-021-00711-y
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40258-021-00711-y
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s40258-021-00711-y?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Christian Schaetti & Mitchell G Weiss & Said M Ali & Claire-Lise Chaignat & Ahmed M Khatib & Rita Reyburn & Radboud J Duintjer Tebbens & Raymond Hutubessy, 2012. "Costs of Illness Due to Cholera, Costs of Immunization and Cost-Effectiveness of an Oral Cholera Mass Vaccination Campaign in Zanzibar," PLOS Neglected Tropical Diseases, Public Library of Science, vol. 6(10), pages 1-10, October.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Aziz, Sonia & Pakhtigian, Emily L. & Akanda, Ali S. & Jutla, Antarpreet & Huq, Anwar & Alam, Munirul & Ashan, Gias U. & Colwell, Rita R., 2021. "Does improved risk information increase the value of cholera prevention? An analysis of stated vaccine demand in slum areas of urban Bangladesh," Social Science & Medicine, Elsevier, vol. 272(C).
    2. Azrah Anparasan & Miguel Lejeune, 2019. "Resource deployment and donation allocation for epidemic outbreaks," Annals of Operations Research, Springer, vol. 283(1), pages 9-32, December.
    3. Liv Solvår Nymark & Alex Miller & Anna Vassall, 2021. "Inclusion of Additional Unintended Consequences in Economic Evaluation: A Systematic Review of Immunization and Tuberculosis Cost-Effectiveness Analyses," PharmacoEconomics - Open, Springer, vol. 5(4), pages 587-603, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:aphecp:v:20:y:2022:i:3:d:10.1007_s40258-021-00711-y. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.